| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.888001 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107171849 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 200604t20202020onc ob f00| 0 eng d |
|---|
| 020 | |a9780660351278 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-268/2020E-PDF |
|---|
| 245 | 00|aRecommendation on the use of live attenuated influenza vaccine (LAIV) in HIV-infected individuals. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (42 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Recommandation sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH. |
|---|
| 500 | |a"An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)." |
|---|
| 500 | |aCover title. |
|---|
| 504 | |aIncludes bibliographical references (pages 38-41). |
|---|
| 650 | 0|aHIV-positive persons|zCanada. |
|---|
| 650 | 0|aInfluenza vaccines|zCanada. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tRecommandation sur le recours au vaccin vivant atténué contre l’influenza (VVAI) chez les personnes infectées par le VIH. |w(CaOODSP)9.888002 |
|---|
| 856 | 40|qPDF|s1.42 MB|uhttps://publications.gc.ca/collections/collection_2020/aspc-phac/HP40-268-2020-eng.pdf |
|---|
| 986 | |a200073 |
|---|